J&J, Tolmar Settle Patent Case Over Antipsychotic Drug
A federal court Wednesday signed off on a consent judgment in a patent case brought by a Johnson & Johnson unit that prevents Tolmar Inc. from selling a generic version of...To view the full article, register now.
Already a subscriber? Click here to view full article